TT-01488

N/A

Report date: 2022/04/20 11:18:49
NME

Base Information

Drug NameTT-01488
Drug Alias NameTT-01488
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsSolid tumoursLymphoma, B-CellLeukemia, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTransThera Sciences (Nanjing) Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTransThera Sciences (Nanjing) Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, B-CellLeukemia, B-Cell
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A